PFE

Pfizer Inc

Feb 27 • 09:32AM ET

27.15

+0.05 0.18 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN-D

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Index	S&P 500	P/E	20.04	EPS (ttm)	1.36	Insider Own	0.10%	Shs Outstand	5.69B	Perf Week	1.88%
Market Cap	154.37B	Forward P/E	9.59	EPS next Y	2.83	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	4.99%
Enterprise Value	201.39B	PEG	-	EPS next Q	0.73	Inst Own	67.07%	Short Float	2.58%	Perf Quarter	5.56%
Income	7.75B	P/S	2.47	EPS this Y	-8.17%	Inst Trans	-0.20%	Short Ratio	3.07	Perf Half Y	8.30%
Sales	62.58B	P/B	1.66	EPS next Y	-4.24%	ROA	4.58%	Short Interest	146.38M	Perf YTD	9.04%
Book/sh	16.32	P/C	10.30	EPS next 5Y	-8.76%	ROE	10.59%	52W High	27.94 -2.83%	Perf Year	4.02%
Cash/sh	2.64	P/FCF	14.88	EPS past 3/5Y	-37.12% -3.51%	ROIC	5.16%	52W Low	20.92 29.81%	Perf 3Y	-33.42%
Dividend Est.	1.75 (6.45%)	EV/EBITDA	7.70	Sales past 3/5Y	-14.56% 8.48%	Gross Margin	76.10%	Volatility	1.74% 2.20%	Perf 5Y	-18.93%
Dividend TTM	1.72 (6.34%)	EV/Sales	3.22	EPS Y/Y TTM	-3.74%	Oper. Margin	27.83%	ATR (14)	0.55	Perf 10Y	-5.23%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.97	Sales Y/Y TTM	-1.65%	Profit Margin	12.38%	RSI (14)	55.97	Recom	2.66
Dividend Gr. 3/5Y	2.23% 2.37%	Current Ratio	1.28	EPS Q/Q	-509.90%	SMA20	0.45%	Beta	0.44	Target Price	28.35
Payout	126.47%	Debt/Eq	0.66	Sales Q/Q	-1.16%	SMA50	4.15%	Rel Volume	0.37	Prev Close	27.10
Employees	81000	LT Debt/Eq	0.62	Earnings	Feb 03 BMO	SMA200	8.57%	Avg Volume	47.64M	Price	27.15
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.42% 4.20%	Trades		Volume	973,957	Change	0.18%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-25-26	Initiated	RBC Capital Mkts	Underperform	$25
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40

Show Previous Ratings

Today 08:26AM	Novavax Stock Gains as Q4 Earnings & Sales Beat Estimates (Zacks)
07:01AM	Pfizer (PFE) Secures Full FDA Approval for BRAFTOVI as First-Line Treatment in mCRC (Insider Monkey)
12:07AM	Novavax Q4 Earnings Call Highlights (MarketBeat)
Feb-26-26 07:30PM	Love Dividends? 1 Stock to Buy Now With a Yield Over 6%. (Barchart)
04:11PM	Novavax Inc (NVAX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
04:11PM	Loading…
04:11PM	Top Research Reports for Meta, Netflix & Pfizer (Zacks)
02:24PM	Analyst Report: Viatris Inc. (Morningstar Research)
10:59AM	Aclaris Therapeutics Highlights AD and Asthma Data Catalysts at Oppenheimer Healthcare Conference (MarketBeat)
08:46AM	Novavax shares subdued despite earnings, revenue beat (Investing.com)
08:30AM	Novavax, Inc. Q4 2025 Earnings Call Summary (Moby)
04:32AM	Cardiff Oncology Spotlights Onvansertib Data at Oppenheimer: 72% ORR in RAS-Mutant mCRC (MarketBeat)
Feb-25-26 09:50PM	RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds (Insider Monkey)
01:22PM	Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment (Benzinga)
01:20PM	Analyst Report: Haleon plc (Morningstar Research)
11:33AM	Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment (Benzinga)
09:57AM	Loading…
09:57AM	Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie (Investing.com)
08:49AM	Can J&J Sustain Its Double-Digit Oncology Growth Streak? (Zacks)
08:26AM	Pfizer Stock: Is PFE Underperforming the Healthcare Sector? (Barchart)
Feb-24-26 04:29PM	'Stablecoin Summer': Stripe Makes Tender Offer at $159 Billion Valuation (decrypt)
02:45PM	Pfizer Secures $495 Million China Obesity Drug Deal (GuruFocus.com)
02:29PM	U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer (Business Wire)
10:44AM	Arvinas Q4 Earnings Call Highlights (MarketBeat)
09:35AM	Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity (PR Newswire)
08:27AM	What's Going On With Kyntra Bio Stock Tuesday? (Benzinga)
06:00AM	Novo to cut GLP-1 drug prices; Palvella soars on study data (BioPharma Dive)
Feb-23-26 10:45AM	Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings? (Zacks)
10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:00AM	Telescope Innovations Installs Second Self-Driving Lab at Pfizer (TMX Newsfile)
Feb-20-26 11:02AM	Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot (Benzinga)
10:46AM	Loading…
10:46AM	AstraZeneca vs. Pfizer: Which Pharma Giant Has the Edge in 2026? (Zacks)
08:08AM	Barclays launches U.S. biopharma coverage with four preferred picks (Investing.com)
03:58AM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
03:34AM	Pfizer Inc (PFE) Announces Positive Results from BREAKWATER Trial (Insider Monkey)
Feb-19-26 10:15AM	Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure (Zacks)
09:53AM	Where is Pfizer Inc. (PFE) Headed? (Insider Monkey)
Feb-18-26 11:20AM	Moderna stock surges as FDA reverses course, agrees to review new flu shot (Yahoo Finance)
03:20AM	Analyst Report: Pfizer Inc. (Morningstar Research)
Feb-17-26 11:04AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily)
10:30AM	CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock? (Zacks)
10:15AM	Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial (Benzinga)
06:45AM	Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer (Business Wire)
Feb-14-26 02:04PM	Oric Pharmaceuticals Highlights 2025 Milestones at Guggenheim, Targets Phase 3 Prostate Trial in 1H25 (MarketBeat)
01:28AM	Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings (Insider Monkey)
Feb-13-26 08:57PM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
04:57PM	Analyst Report: Zoetis Inc. (Morningstar Research)
09:57AM	Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds? (Insider Monkey)
Feb-12-26 12:00PM	Kahn Brothers Reduces Stake in Pfizer Inc by 21.66% (GuruFocus.com)
10:38AM	MDGL Strengthens MASH Franchise With New Genetic Approaches (Zacks)
08:00AM	Here Are Thursdays Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More (24/7 Wall St.)
Feb-11-26 01:30PM	Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish (Barchart)
12:57PM	Pharma companies left out of Trump's drug-pricing deals look for way in (Reuters)
10:35AM	Pfizer (PFE) Closes 2025 on Solid Note, Returns $9.8B to Shareholders (Insider Monkey)
08:09AM	Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff? (Zacks)
08:01AM	CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside (Zacks)
Feb-10-26 04:51PM	Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. (Barrons.com)
11:06AM	Will BMY's Legacy Portfolio Decline Weigh on Its 2026 Top Line? (Zacks)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
06:41AM	Pfizer Inc. (PFE) Announces FDA's Grant of Priority Review for HYMPAVZI (marstacimab) sBLA (Insider Monkey)
12:37AM	5 Revealing Analyst Questions From Pfizer's Q4 Earnings Call (StockStory)
Feb-09-26 10:29AM	BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
09:11AM	Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4? (Zacks)
Feb-07-26 08:00AM	Pfizer CEO discusses the company's GLP-1 weight-loss drug pipeline (Yahoo Finance Video)
Feb-06-26 05:13PM	TrumpRx Is Here. Most People Won't Benefit. (Barrons.com)
03:37PM	3 High-Yield Dividend Stocks Perfect For Retirees (24/7 Wall St.)
11:58AM	TrumpRx launches to slash drug prices for cash-paying US patients (Pharmaceutical Technology)
11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
08:00AM	China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse. (Investor's Business Daily)
07:45AM	5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now (24/7 Wall St.)
07:08AM	White Houses online service for drug sales debuts with limited impact on prices (BioPharma Dive)
06:45AM	FDA Grants Priority Review for HYMPAVZI (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need (Business Wire)
12:13AM	Trump Says People Will 'Save A Lot Of Money And Be Healthy' With Launch Of TrumpRx Website - But Will It Actually Fill Prescriptions? (Benzinga)
Feb-05-26 09:17PM	Trump launches TrumpRX website offering discounted prescription drugs (Investing.com)
08:06PM	Adaptive Biotechnologies Q4 Earnings Call Highlights (MarketBeat)
07:09PM	Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans (Business Wire)
05:22PM	Pfizer Pops on Q4 Results-But This May Be the Catalyst That Matters Most (MarketBeat)
04:17PM	TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. (MarketWatch)
01:29PM	Bristol Myers Earnings Reveal Struggling Legacy Drug Business. Why the Stock Is Rising. (Barrons.com)
10:49AM	Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat Estimates (Zacks)
09:55AM	This Medical Technology Leader Sees Growth Into The 2040s (Investor's Business Daily)
08:21AM	The Week Ahead: Inflation Data Hits Amid Earnings Season (Schaeffer's Research)
07:58AM	Rapid Innovation is Reshaping Oncology: Stocks in Focus (Zacks)
03:00AM	Big Pharma CEOs set sights on massive growth in years to come (Pharma Voice)
Feb-04-26 09:35PM	Pfizer Inc. (PFE): A Bull Case Theory (Insider Monkey)
01:11PM	Pfizer (PFE) Announces Positive Phase 2b Results for Obesity Drug Showing 12.30% Weight Loss (Insider Monkey)
11:40AM	Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 (Motley Fool)
08:45AM	Novo Nordisk: Pfizer weight loss drug offers credible new competition (Proactive)
04:51AM	Earnings roundup: Amgen vs. FDA, Pfizers defense and Mercks $70B-in-sales plan (BioPharma Dive)
01:08AM	Pfizer Q4 Earnings Call Highlights (MarketBeat)
12:32AM	PFE Q4 CY2025 Deep Dive: Obesity Pipeline and Cost Discipline Face Post-COVID Headwinds (StockStory)
Feb-03-26 11:35PM	Will the Market Crash in 2026? Here's What History Says and What to Do About It (Motley Fool)
11:09PM	Asian shares gained and gold and silver climb higher after a retreat on Wall St (Associated Press Finance)
09:49PM	Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off (Motley Fool)
06:03PM	Stocks to Watch Tuesday Recap: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)
04:36PM	These Stocks Are Todays Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More (Barrons.com)
04:26PM	Stocks Tumble on AI Disruption Fears (Barchart)
04:09PM	Pfizer Dives; Why Lilly's Zepbound Still Looks Like The Weight-Loss Heavyweight (Investor's Business Daily)
04:03PM	Pfizer Inc (PFE) Q4 2025 Earnings Call Highlights: Strategic Acquisitions and Revenue Guidance ... (GuruFocus.com)
03:14PM	Analyst Report: Pfizer Inc. (Morningstar Research)
03:05PM	Stocks to Watch Tuesday: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience